@usepapertrace Thank you. All details on sources and scoring are on the GitHub. The only thing we cannot share are the public database, which you can download yourself. PMIDs are not comprehensive but we have tried to give evidence traces to as many analysis modes as we can.
🚀 ISEV 2026 ✨
👩🏻🔬 A fav SNEV event is back: Meet the Experts - more details soon!
🎯 We’re also organizing a Career Path session
🌎 Some SNEV board members will be heading to Puerto Rico 🇵🇷
💬 If you’d like to connect or learn more about SNEV, reach out to them (info below!)
📣 Join us for a new EV Fundamental Biology Talk! 📣
🎙️Dr. Mohsin Shafiq, Institute of Neuropathology, University Medical Center Hamburg-Eppendorf (UKE) 🇩🇪
🧪 Title: EVs in Alzheimer’s Disease: From Plaque Pathology to Neuronal Network Function
🕘 https://t.co/3HO32Mh2p0
📣EV Isolation and Characterization Series
🎙️Dr. Fabrice Lucien-Matteoni (Mayo Clinic) will discuss pre-analytical standardization, quality control, and transparent reporting in blood EV research: the MIBlood-EV initiative
🎙️Heather and Jonathan
🕘 https://t.co/n61yO3KdSp
In three days!
MOVE Experiences and Challenges in EV Research
Speakers:
Dr. Nea Korvenlaita (Johns Hopkins University)
Dr. Claudia Reyes Goya (Karolinska Institutet)
Dr. Jonathan Weerakkody (Yale School of Medicine)
⏰TimeZone: https://t.co/nQ36KAWKOj
🧵 Many “hot takes” about the reduction of @NIH indirect grant costs to 15%.
Let’s lay out the facts about the university grant management process & accounting. And then use this to project likely short and longer term impacts of the policy.
Congratulations to Assistant Professor of #Pathology @dR_sathish_Lab, who is 1 of 3 @YaleMed faculty members awarded a patent for inventing a device that can study molecular interactions on lipid membranes w/single-molecule resolution. https://t.co/LzqaPMNSJt
Excited to share our latest review on using exosomes as blood-based biomarkers for neurodegenerative diseases. Promising insights, but still challenges ahead for clinical use.
https://t.co/EOEMoNcJTU